Double-Duty heart pill trial aims to slash future cardiac crises
NCT ID NCT05782777
Summary
This study is testing if a two-drug cholesterol-lowering combination works better than the standard single drug to prevent future heart attacks, strokes, or death in people who have had a stent placed. It will enroll over 4,300 adults who recently received a new type of drug-coated heart stent. The goal is to see if the combination therapy provides stronger, long-term protection against serious heart problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE REQUIRING CORONARY REVASCULARIZATION WITH NEWER GENERATION DES IMPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yonsei University Health System, Severance Hospital
RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.